4.10
price down icon9.89%   -0.45
after-market アフターアワーズ: 4.10
loading
前日終値:
$4.55
開ける:
$4.53
24時間の取引高:
104.98K
Relative Volume:
0.47
時価総額:
$144.84M
収益:
-
当期純損益:
-
株価収益率:
-2.0724
EPS:
-1.9784
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+1.74%
1か月 パフォーマンス:
+58.91%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
Value
$4.07
$4.5775
1週間の範囲:
Value
$3.92
$4.75
52週間の値動き範囲:
Value
$2.34
$8.79

Anteris Technologies Global Corp Stock (AVR) Company Profile

Name
名前
Anteris Technologies Global Corp
Name
セクター
Healthcare (1149)
Name
電話
651-493-0606
Name
住所
860 BLUE GENTIAN ROAD, EAGAN
Name
職員
0
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
AVR's Discussions on Twitter

AVR を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Instruments & Supplies icon
AVR
Anteris Technologies Global Corp
4.10 144.84M 0 0 0 -1.9784
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
565.94 192.17B 8.71B 2.48B 1.75B 6.82
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
171.02 47.90B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
ALC
Alcon Inc
87.24 47.53B 9.91B 1.02B 665.00M 2.05
Medical Instruments & Supplies icon
RMD
Resmed Inc
246.99 35.88B 5.02B 1.31B 1.56B 8.91
Medical Instruments & Supplies icon
COO
The Cooper Companies, Inc.
80.47 16.25B 3.93B 415.40M 384.70M 2.06

Anteris Technologies Global Corp Stock (AVR) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-01-08 開始されました Lake Street Buy
2025-01-07 開始されました Barclays Overweight
2025-01-07 開始されました Cantor Fitzgerald Overweight
2025-01-07 開始されました TD Cowen Buy

Anteris Technologies Global Corp (AVR) 最新ニュース

pulisher
04:55 AM

Anteris Technologies advances toward PARADIGM trial after key regulatory and clinical milestones - Proactive financial news

04:55 AM
pulisher
May 13, 2025

Anteris scales for pivotal PARADIGM Trial, plunging R&D investment into clinical activities - Proactive financial news

May 13, 2025
pulisher
May 13, 2025

The morning catch up: ASX to extend gains as global optimism lifts markets - Proactive financial news

May 13, 2025
pulisher
May 13, 2025

Anteris Technologies Advances Clinical Trial Efforts with DurAVR® THV - TipRanks

May 13, 2025
pulisher
May 13, 2025

Anteris Technologies Reports Q1 2025 Results and Strategic Fund Allocation - TipRanks

May 13, 2025
pulisher
May 13, 2025

Anteris Announces Results for the First Quarter of 2025 - The Manila Times

May 13, 2025
pulisher
Apr 29, 2025

Anteris Technologies Files Amendment to Annual Report - TipRanks

Apr 29, 2025
pulisher
Apr 28, 2025

Anteris Technologies Announces Cessation of Certain Securities - TipRanks

Apr 28, 2025
pulisher
Apr 25, 2025

Anteris Technologies Global Corp. (AVR) Receives a Buy from Lake Street - The Globe and Mail

Apr 25, 2025
pulisher
Apr 24, 2025

ASX Runners of the Week: Redstone Resources, Anteris & Jindalee Lithium - businessnews.com.au

Apr 24, 2025
pulisher
Apr 21, 2025

Cantor Fitzgerald maintains Anteris stock Overweight with $9 target By Investing.com - Investing.com South Africa

Apr 21, 2025
pulisher
Apr 21, 2025

Cantor Fitzgerald maintains Anteris stock Overweight with $9 target - Investing.com

Apr 21, 2025
pulisher
Apr 07, 2025

Anteris Technologies Announces Cessation of Securities - TipRanks

Apr 07, 2025
pulisher
Apr 07, 2025

Anteris Technologies Announces New Securities Quotation - TipRanks

Apr 07, 2025
pulisher
Apr 03, 2025

NanoVibronix (NASDAQ:NAOV) & Anteris Technologies Global (NASDAQ:AVR) Head to Head Review - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

Anteris Technologies Reports March 2025 CDI Adjustments - TipRanks

Apr 02, 2025
pulisher
Mar 31, 2025

Anteris Technologies Marks Clinical Milestone with DurAVR® THV By Investing.com - Investing.com Canada

Mar 31, 2025
pulisher
Mar 31, 2025

Anteris reports over 100 patients treated with new heart valve By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Anteris Technologies Hits Milestone with DurAVR® Heart Valve Treatment - Zenopa

Mar 31, 2025
pulisher
Mar 31, 2025

Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV - GlobeNewswire

Mar 31, 2025
pulisher
Mar 31, 2025

Anteris reports over 100 patients treated with new heart valve - Investing.com

Mar 31, 2025
pulisher
Mar 31, 2025

Anteris Technologies announces 100 patients treated with DurAVR THV - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

Anteris Technologies Achieves Key Milestone in Cardiac Care - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

Anteris Technologies Marks Clinical Milestone with DurAVR® THV - Investing.com

Mar 31, 2025
pulisher
Mar 30, 2025

Anteris Technologies Achieves Milestone with DurAVR® Heart Valve - TipRanks

Mar 30, 2025
pulisher
Mar 30, 2025

Anteris Technologies marks clinical milestone with more than 100 patients treated using flagship DurAVR® THV - Proactive financial news

Mar 30, 2025
pulisher
Mar 25, 2025

ASX Health Stocks: Anteris plans for US IPO and listing on Nasdaq - MSN

Mar 25, 2025
pulisher
Mar 24, 2025

Head to Head Survey: Anteris Technologies Global (NASDAQ:AVR) & United Health Products (OTCMKTS:UEEC) - Defense World

Mar 24, 2025
pulisher
Mar 21, 2025

Anteris Technologies reports one-year patient outcomes for DurAVR THV - TipRanks

Mar 21, 2025
pulisher
Mar 21, 2025

Anteris shares rise on positive valve trial results By Investing.com - Investing.com Canada

Mar 21, 2025
pulisher
Mar 21, 2025

Anteris Reports One-Year Patient Outcomes for DurAVR® THV - The Manila Times

Mar 21, 2025
pulisher
Mar 21, 2025

Anteris shares rise on positive valve trial results - Investing.com India

Mar 21, 2025
pulisher
Mar 21, 2025

Anteris Technologies Unveils Positive DurAVR® Patient Outcomes - TipRanks

Mar 21, 2025
pulisher
Mar 21, 2025

Anteris Technologies delivers strong one-year results for DurAVR® Transcatheter Heart Valve - Proactive financial news

Mar 21, 2025
pulisher
Mar 18, 2025

Analyzing Anteris Technologies Global (NASDAQ:AVR) & CollPlant Biotechnologies (NASDAQ:CLGN) - Defense World

Mar 18, 2025
pulisher
Mar 14, 2025

Anteris Technologies Global (NASDAQ:AVR) Stock Price Down 6.2% – What’s Next? - Defense World

Mar 14, 2025
pulisher
Mar 13, 2025

Anteris Technologies: Advancing Toward FDA Approval with Positive Buy Rating - TipRanks

Mar 13, 2025
pulisher
Mar 13, 2025

Anteris Technologies reports annual financial results By Investing.com - Investing.com South Africa

Mar 13, 2025
pulisher
Mar 13, 2025

Anteris Technologies reports annual financial results - Investing.com India

Mar 13, 2025
pulisher
Mar 13, 2025

Anteris Technologies 2024 financials strong following Nasdaq debut, with plans for heart valve pivotal trial this year - Proactive financial news

Mar 13, 2025
pulisher
Mar 13, 2025

Anteris Technologies: A Trailblazing Year of Innovation and Expansion - Kondor EXP

Mar 13, 2025
pulisher
Mar 12, 2025

The morning catch up: ASX to reverse losses despite war of words over tariffs - Proactive financial news

Mar 12, 2025

Anteris Technologies Global Corp (AVR) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$71.14
price down icon 3.24%
$55.36
price down icon 3.08%
$187.65
price down icon 1.45%
medical_instruments_supplies WST
$206.69
price down icon 4.25%
medical_instruments_supplies BAX
$30.32
price down icon 2.66%
medical_instruments_supplies COO
$80.47
price down icon 1.58%
大文字化:     |  ボリューム (24 時間):